Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Endocrinology

Long-Term Outcomes & Complications

At a Glance

Even with a strict galactose-free diet, patients with galactosemia can face long-term complications because the body naturally produces its own galactose. Common outcomes include Primary Ovarian Insufficiency (POI) in females, Childhood Apraxia of Speech, and motor or neurological challenges.

While the galactose-restricted diet is life-saving in the newborn period, many families find it frustrating when long-term challenges still arise. It is important to understand that these complications are not a sign of “dietary failure.”

Even with a perfect diet, the body continues to produce its own galactose internally—a process called endogenous production [1][2].

Do not let this discourage you from following the diet. The restricted diet removes the vast majority of the toxic burden and is absolutely essential for preventing severe liver damage, brain injury, and fatal crises [3][4]. Endogenous production simply explains why careful long-term monitoring is required, not that the diet is ineffective [5].

Reproductive Health: Primary Ovarian Insufficiency (POI)

One of the most common complications for females with Classic Galactosemia is Primary Ovarian Insufficiency (POI), which affects roughly 80-90% of patients [1][6].

  • What it is: The ovaries stop functioning earlier than expected, often before or during puberty [7]. This happens because the toxic buildup of sugar metabolites causes accelerated depletion of ovarian follicles (eggs) [2][8].
  • Monitoring: Doctors use specific blood tests to track ovarian health. AMH (Anti-Müllerian Hormone) levels help estimate the remaining egg supply, while FSH (Follicle-Stimulating Hormone) levels rise when the ovaries are struggling [9][7].
  • Empowering Fact: While POI is common, advances in fertility preservation technologies (such as egg or tissue freezing) offer growing hope for families [2][6]. Furthermore, spontaneous natural conception has occasionally occurred even in the setting of ovarian failure [7][8].

Speech and Language: Early Intervention

Many children with galactosemia experience delays in speech and language. A common diagnosis is Childhood Apraxia of Speech (CAS), where the brain struggles to coordinate the complex muscle movements needed to speak clearly [10][11].

  • Proactive Action: You do not have to wait for a delay to occur. Proactive interventions like Babble Boot Camp are designed to start in infancy (as early as 6-24 months) [12][11]. This therapy focuses on increasing a baby’s vocalizations and communication milestones before severe speech problems manifest [10].
  • Consistency: Early and intensive speech therapy is highly effective at improving long-term communication outcomes [10].

Neurological and Motor Health

As children grow, the nervous system may show signs of long-term stress from the condition [13][11].

  • Motor Challenges: Some children develop ataxia (clumsiness or lack of coordination) or tremors (shaking in the hands or limbs) [11].
  • Cognitive Support: Learning disabilities or processing delays can occur. Early neurodevelopmental assessments can help you secure the right school accommodations (like an IEP or 504 plan) early on [11][14].

A Note on Resilience

Facing these potential outcomes can be daunting. However, knowing about them in advance allows you to be an “early responder.” By utilizing speech therapy, monitoring hormones, and engaging with a specialized care team, you are giving your child the best possible tools to navigate these challenges [11][10].

Common questions in this guide

Why do complications happen even if we follow the galactosemia diet perfectly?
The human body naturally produces its own galactose, a process called endogenous production. While a strict galactose-free diet is essential to prevent life-threatening crises, this internal production can still cause long-term complications over time.
What is Primary Ovarian Insufficiency (POI) in galactosemia?
POI happens when the ovaries stop functioning earlier than expected due to a buildup of sugar metabolites that deplete the egg supply. Doctors monitor this by checking AMH and FSH hormone levels to track ovarian health and remaining egg supply.
Can females with galactosemia have children?
Yes. Advances in fertility preservation technologies, such as egg or tissue freezing, provide growing options for family planning. Additionally, spontaneous natural conception has occasionally occurred even in cases of ovarian failure.
How does galactosemia affect speech and language development?
Many children develop Childhood Apraxia of Speech, where the brain struggles to coordinate the muscle movements needed for clear speech. Proactive speech interventions like Babble Boot Camp can start as early as 6 months to address this before severe delays occur.
What neurological issues should we watch for as a child with galactosemia grows?
As children grow, they may develop motor challenges like ataxia (clumsiness or lack of coordination) or tremors (shaking in the hands or limbs). Learning disabilities or processing delays can also occur, making early neurodevelopmental assessments important.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Why is my child at risk for complications even if I follow the diet perfectly?
  2. 2.At what age should we start monitoring my daughter's AMH and FSH levels?
  3. 3.Can you refer us to a clinic familiar with fertility preservation options for patients with galactosemia?
  4. 4.Can you refer us to a speech-language pathologist who is familiar with 'Childhood Apraxia of Speech' and 'Babble Boot Camp'?
  5. 5.What motor signs, like tremors or balance issues, should I be looking for as my child grows?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    The natural history of classic galactosemia: lessons from the GalNet registry.

    Rubio-Gozalbo ME, Haskovic M, Bosch AM, et al.

    Orphanet journal of rare diseases 2019; (14(1)):86 doi:10.1186/s13023-019-1047-z.

    PMID: 31029175
  2. 2

    Early postnatal alterations in follicular stress response and survival in a mouse model of Classic Galactosemia.

    Hagen-Lillevik S, Johnson J, Lai K

    Journal of ovarian research 2022; (15(1)):122 doi:10.1186/s13048-022-01049-2.

    PMID: 36414970
  3. 3

    Clinical and biochemical phenotypes, genotypes, and long-term outcomes of individuals with galactosemia type I from a single metabolic genetics center in Alberta.

    Almenabawy N, Bahl S, Ostlund AL, et al.

    Molecular genetics and metabolism reports 2024; (38()):101055 doi:10.1016/j.ymgmr.2024.101055.

    PMID: 38469090
  4. 4

    Galactosemia.

    Cerone J, Rios A

    Pediatrics in review 2019; (40(Suppl 1)):24-27 doi:10.1542/pir.2018-0150.

    PMID: 31575690
  5. 5

    Classic Galactosemia: Study on the Late Prenatal Development of GALT Specific Activity in a Sheep Model.

    Coelho AI, Bierau J, Lindhout M, et al.

    Anatomical record (Hoboken, N.J. : 2007) 2017; (300(9)):1570-1575 doi:10.1002/ar.23616.

    PMID: 28545161
  6. 6

    Pathophysiology and management of classic galactosemic primary ovarian insufficiency.

    Hagen-Lillevik S, Rushing JS, Appiah L, et al.

    Reproduction & fertility 2021; (2(3)):R67-R84 doi:10.1530/RAF-21-0014.

    PMID: 35118398
  7. 7

    Fertility in adult women with classic galactosemia and primary ovarian insufficiency.

    van Erven B, Berry GT, Cassiman D, et al.

    Fertility and sterility 2017; (108(1)):168-174 doi:10.1016/j.fertnstert.2017.05.013.

    PMID: 28579413
  8. 8

    Two consecutive pregnancies in a patient with premature ovarian insufficiency in the course of classic galactosemia and a review of the literature.

    Kruszewska J, Laudy-Wiaderny H, Krzywdzinska S, et al.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2022; (38(2)):186-189 doi:10.1080/09513590.2021.1998437.

    PMID: 34730073
  9. 9

    Clinical Utilities of Anti-Müllerian Hormone.

    Russell N, Gilmore A, Roudebush WE

    Journal of clinical medicine 2022; (11(23)) doi:10.3390/jcm11237209.

    PMID: 36498783
  10. 10

    Toward a paradigm shift from deficit-based to proactive speech and language treatment: Randomized pilot trial of the Babble Boot Camp in infants with classic galactosemia.

    Peter B, Potter N, Davis J, et al.

    F1000Research 2019; (8()):271 doi:10.12688/f1000research.18062.5.

    PMID: 32566130
  11. 11

    Motor Milestones: Sensory Motor Trends of Young Children with Classic Galactosemia.

    Armstrong-Heimsoth A, Monroe A, Cupp C, et al.

    Journal of occupational therapy, schools & early intervention 2024; (17(2)):216-227 doi:10.1080/19411243.2023.2192206.

    PMID: 39185447
  12. 12

    Toward Preventing Speech and Language Disorders of Known Genetic Origin: First Post-Intervention Results of Babble Boot Camp in Children With Classic Galactosemia.

    Peter B, Davis J, Cotter S, et al.

    American journal of speech-language pathology 2021; (30(6)):2616-2634 doi:10.1044/2021_AJSLP-21-00098.

    PMID: 34665663
  13. 13

    Galactose-1-phosphate uridyltransferase deficiency: A literature review of the putative mechanisms of short and long-term complications and allelic variants.

    Viggiano E, Marabotti A, Politano L, Burlina A

    Clinical genetics 2018; (93(2)):206-215 doi:10.1111/cge.13030.

    PMID: 28374897
  14. 14

    Abnormal N-glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake.

    Treacy EP, Vencken S, Bosch AM, et al.

    JIMD reports 2021; (61(1)):76-88 doi:10.1002/jmd2.12237.

    PMID: 34485021

This page provides educational information on long-term outcomes and complications associated with galactosemia. It does not replace professional medical advice. Always consult your child's metabolic specialist, endocrinologist, or neurologist regarding their specific symptoms and care plan.

Get notified when new evidence is published on Galactosemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.